Literature DB >> 17308361

Galectin-4 expression in carcinoid tumors.

Kandelaria M Rumilla1, Lori A Erickson, Alan K Erickson, Ricardo V Lloyd.   

Abstract

Galectins (Gal) are an evolutionarily conserved family of 15 carbohydrate-binding proteins (lectins) that are widely distributed in normal and neoplastic cells in a wide range of organisms. They have roles in inflammation, cell adhesion, tumor progression, and metastasis. The function and distribution of Gal-3 and Gal-1 are well characterized, but less information is available about Gal-4. Recent studies have localized Gal-4 in the enterochromaffin cells of the porcine and murine small intestine. We examined the expression of Gal-4 in primary and metastatic human ileal carcinoid tumors as well as in carcinoid tumors of the stomach, lung, and rectum. A total of 44 primary and 42 ileal metastatic carcinoid tumors were examined by immunohistochemistry using tissue microarrays (TMA) with monoclonal antibodies to Gal-4, Gal-3, and Gal-1. Pulmonary (n = 7), rectal (n = 6), and gastric (n = 6) carcinoids were examined with larger tissue sections. A total of 18 pancreatic neuroendocrine tumors were also examined with larger tissue sections. Western blots of three ileal carcinoids were also done. Gal-4 was most highly expressed in the ileal carcinoids and the levels of expression tended to be higher in primary ileal carcinoids compared to the metastatic tumors (p = 0.069). All 18 pancreatic neuroendocrine tumors were negative for Gal-1, Gal-3, and Gal-4. Western blot showed a 32 kDa band for Gal-4 in the ileal carcinoids. Gal-3 and Gal-1 were not detected in the metastatic ileal carcinoids by Western blotting. Gastric carcinoids also expressed Gal-4, but very few pulmonary or rectal carcinoids were positive for Gal-4 (p = 0.002). Lower levels of Gal-1 and Gal-3 expression were present in ileal carcinoids compared to primary pulmonary and rectal tumors. These results show a differential distribution of Gal-4 in carcinoid tumors in different locations of the gastrointestinal tract and the lungs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17308361     DOI: 10.1385/ep:17:3:243

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  27 in total

Review 1.  Expression of galectins in cancer: a critical review.

Authors:  Frédéric van den Brûle; Stèphane Califice; Vincent Castronovo
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 2.  Introduction to galectins.

Authors:  Hakon Leffler; Susanne Carlsson; Maria Hedlund; Yuning Qian; Francoise Poirier
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

3.  Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation.

Authors:  Akira Hokama; Emiko Mizoguchi; Ken Sugimoto; Yasuyo Shimomura; Yosuke Tanaka; Masaru Yoshida; Svend T Rietdijk; Ype P de Jong; Scott B Snapper; Cox Terhorst; Richard S Blumberg; Atsushi Mizoguchi
Journal:  Immunity       Date:  2004-06       Impact factor: 31.745

4.  Aberrant p27kip1 expression in endocrine and other tumors.

Authors:  R V Lloyd; L Jin; X Qian; E Kulig
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

5.  Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.

Authors:  Nathalie Nagy; Hugues Legendre; Olivier Engels; Sabine André; Herbert Kaltner; Kojiro Wasano; Yehiel Zick; Jean-Claude Pector; Christine Decaestecker; Hans-Joachim Gabius; Isabelle Salmon; Robert Kiss
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

6.  Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells. Galectin-4 is localized at sites of cell adhesion.

Authors:  M E Huflejt; E T Jordan; M A Gitt; S H Barondes; H Leffler
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

7.  Immunohistochemical characterization of the distribution of galectin-4 in porcine small intestine.

Authors:  Melissa A Wooters; Michael B Hildreth; Eric A Nelson; Alan K Erickson
Journal:  J Histochem Cytochem       Date:  2005-02       Impact factor: 2.479

8.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

9.  Galectin-4 and small intestinal brush border enzymes form clusters.

Authors:  E M Danielsen; B van Deurs
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

10.  Expression of galectin 4 in the rat small intestine during postnatal development.

Authors:  Elodie Niepceron; Fabienne Simian; Pierre Louisot; Marie-Claire Biol-N'garagba
Journal:  Biochimie       Date:  2004-02       Impact factor: 4.079

View more
  11 in total

Review 1.  Novel therapeutic targets for pancreatic cancer.

Authors:  Shing-Chun Tang; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Overexpression of galectin2 (LGALS2) predicts a better prognosis in human breast cancer.

Authors:  Mandika Chetry; Adheesh Bhandari; Ruiling Feng; Xinming Song; Pintian Wang; Jing Lin
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

3.  Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.

Authors:  Peter M Sadow; Kandelaria M Rumilla; Lori A Erickson; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  Expression patterns suggest that despite considerable functional redundancy, galectin-4 and -6 play distinct roles in normal and damaged mouse digestive tract.

Authors:  Denis Houzelstein; Edouard Reyes-Gomez; Marie Maurer; Pierre Netter; Dominique Higuet
Journal:  J Histochem Cytochem       Date:  2013-01-28       Impact factor: 2.479

5.  Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells.

Authors:  Ana I Belo; Astrid M van der Sar; Boris Tefsen; Irma van Die
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

6.  Galectin-3 and cyclin D1 expression in non-small cell lung cancer.

Authors:  Monika Kosacka; Paweł Piesiak; Aneta Kowal; Marcin Gołecki; Renata Jankowska
Journal:  J Exp Clin Cancer Res       Date:  2011-10-24

7.  Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma.

Authors:  Zhixiong Cai; Yongyi Zeng; Bo Xu; Yunzhen Gao; Sen Wang; Jinhua Zeng; Lihong Chen; Aimin Huang; Xiaolong Liu; Jingfeng Liu
Journal:  Cancer Sci       Date:  2014-10-27       Impact factor: 6.716

Review 8.  The role of galectin-4 in physiology and diseases.

Authors:  Zhan-Qi Cao; Xiu-Li Guo
Journal:  Protein Cell       Date:  2016-03-26       Impact factor: 14.870

Review 9.  The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer.

Authors:  Noemí Manero-Rupérez; Neus Martínez-Bosch; Luis E Barranco; Laura Visa; Pilar Navarro
Journal:  Cells       Date:  2020-03-11       Impact factor: 6.600

10.  Role of galectins in lung cancer.

Authors:  Wei-An Chang; Ming-Ju Tsai; Po-Lin Kuo; Jen-Yu Hung
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.